(lp0
S'PDL BioPharma Inc.  Plunges 5.09% on March 22 Equities.com - 9 hours ago PDL BioPharma Inc.  had a rough trading day for Wednesday March 22 as shares tumbled 5.09%, or a loss of $-0.11 per share, to close at $2.05.Zacks: PDL BioPharma Inc  Given Average Rating of  by Brokerages - Petro Global News 24'
p1
aS'Today Analysts Focus on PDL BioPharma, Inc. , American Outdoor Brands ... StockNewsJournal - 16 hours ago PDL BioPharma, Inc.  have shown a high EPS growth of -6.60% in the last 5 years and has earnings decline of -81.00% yoy.'
p2
aS"Why PDL BioPharma Inc. Is Down 14.8% Today Motley Fool - Nov 23, 2016 Shares in PDL BioPharma  are tumbling 14.8% at 12:30 p.m. EST Wednesday after management closed on a $150 million convertible notes offering and Eli Lilly &amp; Co.Company Update : Here's Why PDL BioPharma Inc Shares Are Slumping ... - Smarter Analyst"
p3
aS"Better Buy: PDL BioPharma, Inc. vs. Johnson &amp; Johnson Motley Fool - Feb 27, 2017 Biotech finance specialist PDL Biopharma  has been suffering a prolonged market thrashing that's driven its stock price down about 75% over the past three years.Stock Returns: Cytokinetics, Incorporated  versus PDL BioPharma ... - CML NewsPDL BioPharma, Inc.  shows monthly volitility of 3.49% - The Newburgh Press"
p4
aS'PDL BioPharma to Present at Two Upcoming Investor Conferences PR Newswire  - Mar 2, 2017 PDL has committed over $1.4 billion and funded approximately $1.1 billion in these investments to date. PDL is headquartered in Incline Village, Nevada.PDL BioPharma Inc.: PDL BioPharma to Present at Two Upcoming Investor Conferences - The Wall Street TranscriptPDL BioPharma reports 4Q loss - Yahoo Finance'
p5
aS'PDL BioPharma: 2017 Could Be A Game-Changer Seeking Alpha - Mar 3, 2017 PDLI is a unique company in the biotech world. Traditionally, their business revolved primarily around purchasing income generating assets in the biotech sector, such as patents or providing debt structures for biotech firms at high interest rates.'
p6
aS'PDL BioPharma Inc.  Moves Higher on Volume Spike for March 17 Equities.com - Mar 17, 2017 PDL BioPharma Inc.  traded on unusually high volume on Mar. 17, as the stock gained 1.38% to close at $2.21. On the day, PDL BioPharma Inc. saw 2.83 million shares trade hands on 9,267 trades. Considering that the stock averages only a daily&nbsp;...The PDL BioPharma Inc  Position Held by Barings LLC - Petro Global News 24Right time to invest?  PDL BioPharma, Inc. , Pulmatrix, Inc.  - USA Commerce Daily'
p7
aS"What are Analyst's Indicators for PDL BioPharma, Inc. , Conduent ... The USA Commerce - Mar 21, 2017 Presently PDL BioPharma, Inc.  stock have an ABR of 1.00. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell."
p8
aS"PDL BioPharma to Present at the Oppenheimer 27th Annual Healthcare Conference Yahoo Finance - Mar 14, 2017 INCLINE VILLAGE, Nev., March 14, 2017 /PRNewswire/ -- PDL BioPharma, Inc.   today announced that John P. McLaughlin, PDL's president and chief executive officer, will present at the Oppenheimer 27th Annual Healthcare Conference next&nbsp;...Hot Stock to Watch: PDL BioPharma, Inc.  - HugoPress"
p9
aS'Stock Returns: BioSpecifics Technologies Corp.  versus PDL ... CML News - 17 hours ago This is a snapshot to compare the stock returns for BioSpecifics Technologies Corp.  versus PDL BioPharma Inc  .'
p10
a.